What is the most effective therapy for preventing NSAID-induced gastropathy? - Wikidata - wikimedia - TriplyDB

What is the most effective therapy for preventing NSAID-induced gastropathy?

What is the most effective therapy for preventing NSAID-induced gastropathy?

http://www.wikidata.org/entity/Q35598100

about

What is the most effective therapy for preventing NSAID-induced gastropathy?

http://www.wikidata.org/entity/Q35598100

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

What is the most effective therapy for preventing NSAID-induced gastropathy?

@ast

What is the most effective therapy for preventing NSAID-induced gastropathy?

@en

type

label

What is the most effective therapy for preventing NSAID-induced gastropathy?

@ast

What is the most effective therapy for preventing NSAID-induced gastropathy?

@en

prefLabel

What is the most effective therapy for preventing NSAID-induced gastropathy?

@ast

What is the most effective therapy for preventing NSAID-induced gastropathy?

@en

P1433

Q35598100-DD5DDFE1-45F5-477B-BAD6-4DE160734489

P1476

Q35598100-58FC5D90-56B1-4137-9A25-771B981A02FF

P2093

Q35598100-E87A7B7B-932B-442B-B94F-DBC6792DFA70

P2860

Q35598100-01B68FB1-603B-4CB7-B8A8-D0D6C093FA3B

Q35598100-0FA281A1-FA84-45C6-818C-592AEEFB1B5A

Q35598100-24BC315F-88A2-4298-95D8-B2CD940D293D

Q35598100-3D0932D7-03C7-4AE6-8E3D-5B0029E50046

Q35598100-5C08D890-CF38-4A75-A2CD-D20A8EA3811C

Q35598100-5CA49230-108E-45EF-84C9-EDD5CC0568A5

Q35598100-7437780D-B124-4517-8EF2-F9BD7681E163

Q35598100-8066A6D5-43FA-4E02-BCF8-199050E93833

Q35598100-83C8FBD2-0A82-4244-B782-38FA9C5D90AB

Q35598100-86D40045-89E8-4FEE-9513-9E9D66439C94

P304

Q35598100-17336D74-D1E1-48A8-9352-AFA1E7791CE0

P31

Q35598100-6322942c-3a5d-4658-9543-51dd9eb4673c

Q35598100-CF58D07B-054E-4BC6-9075-B22F92E5F64D

P356

Q35598100-3B81F41A-9D3B-44FE-8689-ABCBE1D7434D

P433

Q35598100-D3849C07-D092-4EA1-8E90-6BE48ED57A26

P478

Q35598100-DA9B219A-B936-497F-B762-F62FE4D4B23F

P577

Q35598100-F4D18E1D-0DD3-4D4F-BF71-C9453D658257

P698

Q35598100-D1D0B4A6-1650-4804-B39E-AD379C0CEF03

P356

P1433

Journal of Pain and Palliative Care Pharmacotherapy

P1476

What is the most effective therapy for preventing NSAID-induced gastropathy?

@en

P2093

Jane Chandramouli

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

Diclofenac/misoprostol. Pharmacoeconomic implications of therapy.

The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literature.

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.

Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs.

Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology.

P304

23-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/J354V16N02_03

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14650458

http://www.w3.org/2001/XMLSchema#string